GlassScriptPhysician profile
Stephen J Marra
NPI 1689782229
$1,071.48
in general payments reported to CMS, 2019-2025
8 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.84 · 2020: $269 · 2021: $47.12 · 2022: $61.33 · 2023: $84.85 · 2024: $342 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $270.69 | 2019-2023 | Trudi Nav Cable |
| Glaxosmithkline, LLC. | $259.12 | 2022-2025 | Nucala |
| Integra Lifesciences Corporation | $216.76 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Abiomed | $125.00 | 2024 | Impella |
| Getinge USA Sales, LLC | $115.49 | 2020 | |
| Optinose US, INC. | $51.83 | 2020-2023 | |
| Lilly USA, LLC | $21.75 | 2025 | Zepbound |
| Novartis Pharmaceuticals Corporation | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Marra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.